The SITC 2017 Microlearning: Additional Topics Series has been developed with content from abstract and faculty presentations conducted at the Society for Immunotherapy of Cancer 32nd Annual Meeting (SITC 2017). The microlearning series provide a quick, easily accessible format for clinicians and researchers to learn about the latest advances in cancer immunotherapy from experts in the field.
The SITC 2017 Microlearning: Additional Topics series contains three modules.
Module 1: Genetically Modified T Cells for Solid Tumors
Stephen Gottschalk, MD - St. Jude Children's Research Hospital
Module 2: Improvement in Epitope Discovery
Catherine J. Wu, MD - Dana-Farber Cancer Institute
Module 3: Identification of Unique Neoantigen Qualities in Long-Term Pancreatic Cancer Survivors
Vinod Balachandran, MD - Memorial Sloan Kettering Cancer Center
These modules have been designed to meet the educational needs of researchers and healthcare professionals involved in cancer research and clinical care.
Course Available Beginning: August 16, 2018
Course Objectives Upon completion of this activity, participants will be able to:
Explain strategies to identify cancer-specific epitopes for therapeutic use.
Describe strategies concerning modification of T cells to increase tumor targeting.
Define how cancer-specific markers may predict duration of response with immunotherapy.
The SITC connectED education portal is supported by independent educational grants from AstraZeneca Pharmaceuticals LP and Merck & Co., Inc.
Cookies are small pieces of information that are stored by your browser on your computerâ€™s hard drive.
You can delete or block cookies within your browser settings.
Should you opt to do this, some parts of our site may not work.
For more information, including instructions on how to remove the cookies that have been placed,